Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on Sep 10, 2024 4:46pm
100 Views
Post# 36217389

Four20 Pharma seeing massive growth in Germany

Four20 Pharma seeing massive growth in Germany

Germany: Doctors from 16 specialties can now prescribe cannabis


https://cannareporter.eu/en/2024/07/19/Germany-doctors-from-16-specialties-can-now-prescribe-cannabis-without-insurance-approval/

Medical cannabis in Germany is one of the few countries globally where the treatment can be covered under the public health insurance system. 

https://businessofcannabis.com/german-medical-cannabis-associations-call-for-wider-regulatory-reform/

Four20 Pharma Germany is blowing up, Q3 numbers will start to separate CURA from the rest of the pac. 

https://www.mynewsdesk.com/de/420pharma/news/wdr-zu-gast-bei-four-20-pharma-ein-blick-hinter-die-kulissen-des-wachsenden-medizinalcannabis-unternehmens-486966

Professionals from SC Paderborn 07 look behind the scenes at Four 20 Pharma 

https://www.youtube.com/watch?v=-JP9_vm2-70&ab_channel=Four20PharmaGmbH
<< Previous
Bullboard Posts
Next >>